参考文献 References
[1] He Z, Wu X, Zhang W, et al. Effect of combined treatment with linezolid and ulinastatin on respiratory function and serum inflammatory factors in elderly patients with severe pneumonia[J]. Tropical Journal of Pharmaceutical Research, 2022, 21(7): 1543-1548.
[2] Kato H, Hagihara M, Asai N, et al. Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus[J]. Journal of global antimicrobial resistance, 2021, 24: 98-105.
[3] Kong D, Liu X, Li X, et al. Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model[J]. Bioscience Reports, 2019, 39(9): BSR20182455.
[4] Wu W, Li L, Duan S, et al. Clinical effectiveness and reliability of linezolid in the treatment of pulmonary tuberculosis complicated with severe pneumonia: a meta-analysis[J]. American Journal of Translational Research, 2022, 14(11): 7622.
[5] Warda A E A, Sarhan R M, Al-Fishawy H S, et al. Continuous versus intermittent linezolid infusion for critically ill patients with hospital-acquired and ventilator-associated pneumonia: efficacy and safety challenges[J]. Pharmaceuticals, 2022, 15(3): 296.
[6] Chen H, Du Y, Xia Q, et al. Role of linezolid combination therapy for serious infections: review of the current evidence[J]. European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39: 1043-1052.
[7] Warda A E A, Sarhan R M, Al-Fishawy H S, et al. Continuous versus intermittent linezolid infusion for critically ill patients with hospital-acquired and ventilator-associated pneumonia: efficacy and safety challenges[J]. Pharmaceuticals, 2022, 15(3): 296.
[8] 陈婷,魏海明,王玮. 利奈唑胺葡萄糖联合头孢哌酮钠舒巴坦钠治疗重症肺炎的临床效果[J]. 临床合理用药,2023,16(29):67-69+73.
[9] 崔华永,裴金盛,向斌,仇正锋. 利奈唑胺联合乙酰半胱氨酸对重症肺炎患者血气指标、炎性因子的影响[J]. 吉林医学,2023,44(6):1567-1571.
[10] Russo A. Spotlight on new antibiotics for the treatment of pneumonia[J]. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2020, 14: 1179548420982786.
[11] 康珍,许承斌,费志永. 双歧杆菌三联活菌联合利奈唑胺治疗对重症肺炎的疗效及对患者血气指标、炎症因子的影响[J]. 中国药物滥用防治杂志,2023,29(6):1016-1019.
[12] 张文凯,谢建威. 盐酸氨溴索联合利奈唑胺治疗重症肺炎患者对血气指标及炎性指标的影响[J]. 中华养生保健,2023,41(4):169-172.
[13] 王恒辉. 利奈唑胺治疗肺结核合并重症肺炎的效果及对机体免疫影响[J]. 江西医药,2022,57(10):1443-1445.
[14] Li Y, Fang Q, Wu Z, et al. Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients[J]. European Journal of Clinical Pharmacology, 2024: 1-10.
[15] 徐敬敬,王运. 血必净联合利奈唑胺治疗老年重症肺炎的效果及对患者血清炎性因子水平的影响[J]. 临床医学工程,2022,29(1):19-20.